Study design and participants
TNBC, mTNBC, NCT02978716
This analysis is based on data from a multicenter, randomized, open-label, phase II trial including patients aged ≥ 18 years with mTNBC who had received up to two prior chemotherapy regimens for locally recurrent TNBC or mTNBC (NCT02978716) [